HomeCompareRHHBF vs MO

RHHBF vs MO: Dividend Comparison 2026

RHHBF yields 2.28% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $51.4K in total portfolio value· pulled ahead in Year 5
10 years
RHHBF
RHHBF
● Live price
2.28%
Share price
$410.32
Annual div
$9.37
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.7K
Annual income
$1,518.26
Full RHHBF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — RHHBF vs MO

📍 MO pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHHBFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHHBF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHHBF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHHBF
Annual income on $10K today (after 15% tax)
$194.20/yr
After 10yr DRIP, annual income (after tax)
$1,290.52/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $24,344.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHHBF + MO for your $10,000?

RHHBF: 50%MO: 50%
100% MO50/50100% RHHBF
Portfolio after 10yr
$54.4K
Annual income
$15,838.71/yr
Blended yield
29.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

RHHBF
Analyst Ratings
3
Buy
5
Hold
1
Sell
Consensus: Hold
Altman Z
5.3
Piotroski
6/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHHBF buys
0
MO buys
0
No recent congressional trades found for RHHBF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHHBFMO
Forward yield2.28%6.36%
Annual dividend / share$9.37$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17%22.6%
Portfolio after 10y$28.7K$80.1K
Annual income after 10y$1,518.26$30,159.17
Total dividends collected$7.3K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: RHHBF vs MO ($10,000, DRIP)

YearRHHBF PortfolioRHHBF Income/yrMO PortfolioMO Income/yrGap
1$10,967$267.32$10,570$780.30+$397.00RHHBF
2$12,056$320.57$11,381$1,032.90+$675.00RHHBF
3$13,285$385.32$12,535$1,392.73+$750.00RHHBF
4$14,679$464.29$14,193$1,920.91+$486.00RHHBF
5← crossover$16,268$560.96$16,618$2,723.68$350.00MO
6$18,086$679.77$20,263$3,993.80$2.2KMO
7$20,178$826.39$25,936$6,098.36$5.8KMO
8$22,599$1,008.16$35,166$9,775.01$12.6KMO
9$25,416$1,234.62$51,026$16,597.78$25.6KMO
10$28,713$1,518.26$80,113$30,159.17$51.4KMO

RHHBF vs MO: Complete Analysis 2026

RHHBFStock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Full RHHBF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this RHHBF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHHBF vs SCHDRHHBF vs JEPIRHHBF vs ORHHBF vs KORHHBF vs MAINRHHBF vs PMRHHBF vs BTIRHHBF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.